A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden
. Purpose: To assess resource utilization and costs associated with glaucoma management in France and Sweden. Methods: A total of 267 patient records (121 in France, 146 in Sweden) with diagnoses of primary open‐angle glaucoma (POAG) and ocular hypertension (OH), treated medically, were reviewed f...
Saved in:
Published in | Acta ophthalmologica Scandinavica Vol. 84; no. 1; pp. 74 - 83 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK; Malden, USA
Blackwell Publishing Ltd/Inc
01.02.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | .
Purpose: To assess resource utilization and costs associated with glaucoma management in France and Sweden.
Methods: A total of 267 patient records (121 in France, 146 in Sweden) with diagnoses of primary open‐angle glaucoma (POAG) and ocular hypertension (OH), treated medically, were reviewed for a 2‐year period (beginning during 1997−99) for relevant clinical and resource utilization data. Economic data were applied to estimate treatment costs.
Results: The annual cost of treating glaucoma was estimated at SEK5305 (€531)/patient in Sweden and €390/patient in France. In both countries, medication costs comprised about half of the total costs. Surgical procedures and hospitalizations represented greater proportions of total cost in France (7.0% and 9.6%, respectively) than in Sweden (3.7% and 0.6%, respectively).
Conclusion: Medication costs represent a high proportion of total treatment costs. These findings highlight the relative importance of medical therapy and of assessing the cost‐effectiveness of medications in glaucoma. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1395-3907 1600-0420 |
DOI: | 10.1111/j.1600-0420.2005.00560.x |